Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

Recruiting now · Not applicable

Conditions studied: Pterygium of Conjunctiva and Cornea

In brief

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.

Key facts

Study ID

NCT03321201

Run by

University of Split, School of Medicine

People needed

164

Starts

2018-05-08

Expected to finish

2026-12-31

Last updated by the study team

2022-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adults (older than 18 years of age)
• both sexes
• primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
• if the patients had a bilateral pterygium, only one eye will be operated

You may not qualify if…

• connective tissue disease
• prior eye surgery
• chronic use of topical drugs (anti-glaucoma drugs)

Where it is running

• University Hospital Split — Split, Croatia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.